Rapid virologic response: a new milestone in the management of chronic hepatitis C.

@article{Poordad2008RapidVR,
  title={Rapid virologic response: a new milestone in the management of chronic hepatitis C.},
  author={Fred F Poordad and K Rajender Reddy and Paul Martin},
  journal={Clinical infectious diseases : an official publication of the Infectious Diseases Society of America},
  year={2008},
  volume={46 1},
  pages={78-84}
}
BACKGROUND Rapid virologic response (RVR), defined as an undetectable serum hepatitis C virus (HCV) RNA level at week 4 of treatment, is emerging as an important milestone in the treatment of patients who have chronic hepatitis C by use of pegylated interferon-alfa and ribavirin--the current standard of care. This assessment is being used to individualize treatment duration, which is currently recommended as 48 weeks in patients infected with HCV genotype 1 (G1) and 24 weeks in those infected… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 49 extracted citations

Hepatitis C virus (HCV) genotype 2a has a better virologic response to antiviral therapy than HCV genotype 1b.

International journal of clinical and experimental medicine • 2015
View 1 Excerpt

Similar Papers

Loading similar papers…